en The pioneers of access: Making Access Happen Magazine issue 4 out now (4 min read) Download Making Access Happen Magazine – Issue 4The word ‘pioneers’ suggests people who achieve a special goal: to be among the first in their endeavors, leading the way for others to follow. Pioneers are courageous (even if they would never describe themselves as such); pioneers are humble – after all, in leading the way, lessons have to be learned. As importantly, pioneers are strong: they persevere despite challenges and setbacks. It’s through efforts, and their example, that our world, and access to healthcare, can improve. I’m pleased to present a variety of stories about healthcare ... Wed, 07 Nov 2018 10:26:26 +0000 21691 How VAMs increase access to healthcare - Addressing unmet medical needs (7 min read) ?While not many people may be familiar with the term ‘value added medicines,’ patients are familiar with problems they have when they use existing medicines. This is why I usually describe a VAM as a better version of the best available existing generic medicine – for example, by making it easier and less complicated to take, by changing the side effect profile or by combining two effective medicines into one. Another example is when a generic medicine used for one medical condition can be shown – through generation of appropriate data – to also benefit patients with a separate, unrelated ... Mon, 05 Nov 2018 14:00:59 +0000 21686 Redesigning medicines: New options for patientcentric treatments (5 min read) A crying toddler, sick with pneumonia, needs a dose of antibiotics. His mother has the medication – but first she has to prepare it. This means adding water to a gritty-tasting powder in a bottle, then extracting the liquid mixture at a precise amount into a syringe. Now she has to try to get the liquid into the mouth of the feverish, cranky child. Already uncomfortable, the child jerks away from the syringe coming at him – and the antibiotic ends up spilled all over his shirt. Now imagine the benefit for the young patient, and the relief for his mother, when this medicine is available as a ... Mon, 05 Nov 2018 13:45:47 +0000 21681 Interview: Why medical cannabis should be used only in extreme cases (3 min read) Do you prescribe medical cannabis to your patients, and why?Dr. Claude Cyr: I prescribe medical cannabis for a limited number of conditions and mostly for pain relief. But, for me, it still is a last resort medication, for example in cancer and palliative care. Patients sometimes come to my office asking for medical cannabis as a first line treatment for chronic non-cancer pain after having tried one or two other medications. They often haven’t had physiotherapy or steroid injections or any other type of medication. So I send them back to their general practitioner and explain that they need ... Mon, 05 Nov 2018 12:12:38 +0000 21676 Pioneering treatment options: How medical cannabis improves patients’ lives (11 min read) James O’Hara’s illness had taken over his life. A life-long migraine sufferer, in his 50s he began experiencing sudden seizures. For about two weeks after each seizure, O’Hara was left in a state of confusion and with poor memory. “I couldn’t function properly,” he explains from his hometown of Toronto, Canada. His neurologists ran a battery of tests including MRIs and CAT scans. After they diagnosed focal awareness seizures, O’Hara received standard anti-seizure medication. But his seizures continued, no matter which treatment he was given. And the medications brought their own side effects ... Mon, 05 Nov 2018 11:21:28 +0000 21671 Interview: Medical cannabis is a scientifically reasonable option (4 min read) Do you prescribe medical cannabis to your patients, and why?Dr. Blake Pearson: For some of my patients, traditional pharmaceutical treatments weren't effective, or patients couldn’t tolerate the side effects. So that’s when I first started to prescribe medical cannabis. I continued to prescribe it because of the positive results, with less risk of serious side effects. I educated myself on the endocannabinoid system. And once I understood the underlying physiology, I had to acknowledge that medical cannabis is a scientifically reasonable option for the treatment of certain conditions.I also ... Fri, 02 Nov 2018 12:56:55 +0000 21661 Drones for health – How ‘sky ambulances’ save lives (13 min read) [[{"fid":"5551","view_mode":"default","fields":{"format":"default"},"link_text":null,"type":"media","field_deltas":{"6":{"format":"default"}},"attributes":{"class":"media-element file-default","data-delta":"6"}}]]Hundreds of people line a fence in the Muhanga district, Rwanda, and were staring curiously at a lawn where a small plane, not bigger than an adult arm span, was placed on a metal ramp. Their eyes tried to follow as, within seconds, the tiny plane soared into the air and disappeared into the horizon. At the same time, dozens of kilometers away, beyond impassable mountains and ... Wed, 05 Sep 2018 13:49:19 +0100 21586 Protecting Patients: The Fight Against Counterfeit Medicines (14 min read) [[{"fid":"4891","view_mode":"default","fields":{"format":"default"},"type":"media","field_deltas":{"9":{"format":"default"}},"link_text":null,"attributes":{"class":"media-element file-default","data-delta":"9"}}]]From: Drug Safety and Quality: Protecting the Patient, the Sandoz B2B magazineMyanmar, 2005: More than half a million people were infected with malaria. So it was not surprising when, in February, a young man went to a local hospital with a high fever. He complained of headaches, chills and nausea. The doctors diagnosed malaria right away and prescribed artesunate, an antimalarial ... Mon, 19 Feb 2018 11:10:18 +0000 21406 Viewpoint: The biosimilars breakthrough (3 min read) [[{"fid":"4736","view_mode":"default","fields":{"format":"default","filename_field[en][0][value]":"Paul_Cornes.jpeg","field_file_image_alt_text[en][0][value]":"Paul Cornes","field_file_image_title_text[en][0][value]":"Paul Cornes","field_caption[en][0][value]":"Paul Cornes, M.D., is a Consultant Oncologist in Bristol, UK, with the Comparative Outcomes Group, a research cooperative that is interested in patient outcomes at affordable costs."},"type":"media","field_deltas":{"1":{"format":"default","filename_field[en][0][value]":"Paul_Cornes.jpeg","field_file_image_alt_text[en][0][value]":"Paul ... Fri, 29 Dec 2017 10:55:55 +0000 21366 Biosimilars – Ten years of increasing access to state-of-the-art therapies (9 min read) The initial trickle of new biosimilars – versions of powerful biologic therapies – is fast turning into a torrent as their potential gets recognition, and hard-pressed healthcare systems reap the benefits of potentially huge savings. The impact of biosimilars is profound and dynamic, opening up fresh treatment options for patients, widening access to new and existing drugs and liberating resources to explore future medical innovations.The first biosimilar came to life in 2006 with little fanfare, but progress has accelerated year after year, principally in Europe but more recently in the US ... Thu, 09 Nov 2017 12:40:34 +0000 21311 Interview: Joint forces against malaria (3 min read) Are you satisfied with the progress being made on malaria?Yes. In the past 15 years, we’ve had almost 70% fewer deaths due to malaria in Africa, primarily among children under the age of five. That’s extremely good news. And I wish we would talk about such good news much more. The bad-news part of the current situation is that there’s still much that needs to be done including the systematic use of diagnostic tests, increasing distribution and coverage, combating resistance, and ensuring the appropriate treatments are affordable when programs transition from being supported by donor aid. But ... Tue, 07 Nov 2017 08:49:16 +0000 21306 Bringing medication and medical care to people in crisis – the work of Americares [[{"fid":"4296","view_mode":"default","fields":{"format":"default"},"type":"media","field_deltas":{"4":{"format":"default"}},"link_text":null,"attributes":{"class":"media-element file-default","data-delta":"4"}}]]According to World Health Organization estimates, one in three people worldwide do not have regular access to essential medicines.1   Many of these 2.33 billion people are already vulnerable to poverty-associated health risks. For people without standard medical treatments, common illnesses such as influenza or asthma can become deadly. Americares, a health-focused relief ... Thu, 27 Jul 2017 15:23:27 +0100 21156 Getting medicines to patients – the role of quality logistics (11 min read) [[{"fid":"4106","view_mode":"default","fields":{"format":"default","filename_field[en][0][value]":"Scott Allison _ DHL LSH.jpg","field_file_image_alt_text[en][0][value]":"Scott Allison","field_file_image_title_text[en][0][value]":"","field_caption[en][0][value]":"Scott Allison, President of DHL Life Sciences and Healthcare"},"type":"media","link_text":null,"attributes":{"alt":"Scott Allison","height":"373","width":"280","style":"width: 280px; height: 373px; float: right;","class":"media-element file-default"}}]][[{"fid":"4166","view_mode":"default","fields":{"format":"default"},"type":"media ... Tue, 02 May 2017 10:30:56 +0100 21051 Improving access to biologic medicines through biosimilars (9 min read) [[{"fid":"4176","view_mode":"default","fields":{"format":"default"},"type":"media","attributes":{"class":"media-element file-default"},"link_text":null}]]Biologic medicines, or biologics, have revolutionized therapies for hard-to-treat diseases, including certain types of arthritis and cancer2. And as patents for biologics expire, biosimilars can provide the same results more affordably1. This means that more patients have a better chance of getting treatment, which could significantly improve their lives.One person who got her life back is Amye Leong. As a young woman living in California, ... Fri, 21 Apr 2017 14:14:06 +0100 21041 Lives That Matter (10 min read) [[{"fid":"3596","view_mode":"default","fields":{"format":"default"},"type":"media","link_text":null,"attributes":{"class":"media-element file-default"}}]]In 1960s Great Britain, nobody talked about children with cancer – it was a taboo subject. Even hematologists and oncologists didn't know whether children would survive leukemia or most tumors. Since then, significant progress has been made. For example, in children’s acute lymphoblastic leukemia (the commonest cancer seen in children), survival rates have risen from about 20 percent in the early 1970s to 85-90 percent, at least in high- ... Tue, 20 Dec 2016 12:33:31 +0000 20896 Facing Antimicrobial Resistance (7 min read) [[{"fid":"3616","view_mode":"default","fields":{"format":"default"},"type":"media","link_text":null,"attributes":{"class":"media-element file-default"}}]]Ten million people are in danger. By 2050, infections could kill this many people - every year - if antimicrobial resistance continues to spread. The silent battle between bacteria and modern medicine is everywhere. Certain microbes have developed resistance to formerly effective medicines. They have become stronger than mankind’s attempts to destroy them. Nearly 2,000 people per day die from drug-resistant microbial infections. Margaret ... Mon, 14 Nov 2016 09:45:07 +0000 20721 Joining forces to prevent the “end of modern medicine” (4 min read) [[{"fid":"3266","view_mode":"default","fields":{"format":"default"},"type":"media","link_text":null,"field_deltas":{"1":{"format":"default"}},"attributes":{"class":"media-element file-default","data-delta":"1"}}]]Antibiotics are the cornerstone of modern healthcare. In addition to successfully treating infectious diseases, they are critical to ensuring patient safety during millions of routine in-hospital procedures, ranging from organ transplants and joint replacements through to chemotherapy and pre-natal care.However, as WHO director-general Margaret Chan told a global health conference ... Fri, 30 Sep 2016 14:23:26 +0100 20626 92午夜免费福利757-丝袜美腿